MarketInOut Stock Screener Log In | Sign Up
 

Edwards Lifesciences Corp

NYSE • Healthcare • Medical Devices • Quote as of 07/10/2026 16:00
Edwards Lifesciences Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNYSE
Market Capitalization54,597 mln
Float574 mln
Earnings Date07/23/2026

EPS

1.85
Stretched

P / E

49.84
High premium

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.1
Caution advised

1-Year Forecast

97.31
Modest upside

Relative Strength

73 / 100
Outperforming

Business Description

Founded in 1958 and based in Irvine, California, Edwards Lifesciences develops medical devices aimed at treating serious heart conditions across the United States and global markets. The company is best known for its range of heart valve products, including minimally invasive options that can replace or repair damaged valves without open-heart surgery, sold under brands such as SAPIEN, PASCAL, EVOQUE, and INSPIRIS. Its products reach patients through both a dedicated in-house sales team and independent distribution partners worldwide.

Key Fundamentals

EPS1.85
P/E49.84
ROE10.60
RPS10.80
ROIC17.12
ROA8.18
Interest Cover85.34
EBITDA, mln1,559
EV / EBITDA31.62
EV / EBIT35.26
Revenue, mln6,304
EV / Revenue7.82

Financial Strength

Altman Z-Score13.25
Piotroski F-Score 5 / 9
Beneish M-Score-2.1
Price to Intrinsic Value2.99
Price to Graham Number3.42
1-Year Target Price97.31
Shiller PE Ratio37.32
Short Ratio2.34
Short % of Float2.33

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.29% 17 / 100   
1 Month 5.33% 82 / 100   
2 Months 13.48% 72 / 100   
6 Months 8.7% 60 / 100   
1 Year 19.46% 61 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us